Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Gross, Sascha ^a   Van Wanrooij, Roy L ^a   Nijeboer, Petula ^a   Gelderman, Kyra A ^a   Cillessen, Saskia A G M ^a   Meijer, Gerrit A ^a   Mulder, Chris J J ^a   Bouma, Gerd ^a   Von Blomberg, B Mary E ^a   Bontkes, Hetty J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 5; TIOGUANINE; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE CELIAC DISEASE; ADULT; AGED; ARTICLE; CELIAC DISEASE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GLUTEN FREE DIET; HUMAN; IMMUNE RESPONSE; LAMINA PROPRIA; LEUKOCYTE; MALE; PRIORITY JOURNAL; REFRACTORY CELIAC DISEASE; SMALL INTESTINE; STEM CELL TRANSPLANTATION; TH2 CELL; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; CELIAC DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTESTINE, SMALL; LEUKOCYTES; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84877264588     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/939047     Document Type: Article

References (36)

1. De Re V., Caggiari L., Tabuso M., Cannizzaro R., The versatile role of gliadin peptides in celiac disease. Clinical Biochemistry 2012 10.1016/j.clinbiochem.2012.10.038
2. Meresse B., Malamut G., Cerf-Bensussan N., Celiac disease: an immunological jigsaw. Immunity 2012 36 6 907 919
3. Barone M. V., Zanzi D., Maglio M., Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS One 2011 6 2 e17039
4. Laparra Llopis J. M., Sanz Herranz Y., Gliadins induce TNF α production through cAMP-dependent protein kinase A activation in intestinal cells (Caco-2). Journal of Physiology and Biochemistry 2010 66 2 153 159 2-s2.0-77955097020 10.1007/s13105-010-0020-z
5. Bernardo D., Garrote J. A., Fernández-Salazar L., Riestra S., Arranz E., Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides. Gut 2007 56 6 889 890 2-s2.0-34249828653 10.1136/gut.2006. 118265 (Pubitemid 46854215)
6. Abadie V., Discepolo V., Jabri B., Intraepithelial lymphocytes in celiac disease immunopathology. Seminars in Immunopathology 2012 34 4 551 566
7. Olaussen R. W., Johansen F. E., Lundin K. E. A., Jahnsen J., Brandtzaeg P., Farstad I. N., Interferon- γ -secreting T cells localize to the epithelium in coeliac disease. Scandinavian Journal of Immunology 2002 56 6 652 664 2-s2.0-0036456903 10.1046/j.1365-3083.2002.01195.x (Pubitemid 35454350)
8. Bayardo M., Punzi F., Bondar C., Chopita N., Chirdo F., Transglutaminase 2 expression is enhanced synergistically by interferon-gamma and tumour necrosis factor-alpha in human small intestine. Clinical & Experimental Immunology 2012 168 1 95 104
9. Dørum S., Qiao S. W., Sollid L. M., Fleckenstein B., A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the t-cell response in celiac disease. Journal of Proteome Research 2009 8 4 1748 1755 2-s2.0-65249091991 10.1021/pr800960n
10. Bodd M., Ráki M., Tollefsen S., Fallang L. E., Bergseng E., Lundin K. E. A., Sollid L. M., HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunology 2010 3 6 594 601 2-s2.0-77958169377 10.1038/mi.2010.36
11. Wapenaar M. C., van Belzen M. J., Fransen J. H., Fariña Sarasqueta A., Houwen R. H. J., Meijer J. W. R., Mulder C. J. J., Wijmenga C., The interferon gamma gene in celiac disease: augmented expression correlates with tissue damage but no evidence for genetic susceptibility. Journal of Autoimmunity 2004 23 2 183 190 2-s2.0-8444221894 10.1016/j.jaut.2004.05.004 (Pubitemid 39485800)
12. Furuta S., Goto H., Niwa Y., Ohmiya N., Kamiya K., Oguri A., Hayakawa T., Mori N., Interferon- γ regulates apoptosis by releasing soluble tumor necrosis factor receptors in a gastric epithelial cell line. Journal of Gastroenterology and Hepatology 2002 17 12 1283 1290 2-s2.0-0036435889 10.1046/j.1440-1746.2002.02893.x (Pubitemid 35356965)
13. Monteleone I., Sarra M., Blanco G. D. V., Paoluzi O. A., Franzè E., Fina D., Fabrizi A., MacDonald T. T., Pallone F., Monteleone G., Characterization of IL-17A-producing cells in celiac disease mucosa. Journal of Immunology 2010 184 4 2211 2218 2-s2.0-77949904749 10.4049/jimmunol.0901919
14. Forsberg G., Hernell O., Hammarström S., Hammarström M. L., Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease. International Immunology 2007 19 8 993 1001 2-s2.0-34548561702 10.1093/intimm/dxm077 (Pubitemid 47386924)
15. Mulder C. J. J., Wahab P. J., Meijer J. W. R., Metselaar E., A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. European Journal of Gastroenterology and Hepatology 2001 13 10 1183 1188 2-s2.0-0034759899 10.1097/00042737-200110000-00010 (Pubitemid 33015884)
16. Malamut G., Meresse B., Cellier C., Cerf-Bensussan N., Refractory celiac disease: from bench to bedside. Seminars in Immunopathology 2012 34 4 601 613
17. Verbeek W. H. M., Goerres M. S., von Blomberg B. M. E., Oudejans J. J., Scholten P. E. T., Hadithi M., Al-Toma A., Schreurs M. W. J., Mulder C. J. J., Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Clinical Immunology 2008 126 1 48 56 2-s2.0-37249046024 10.1016/j.clim.2007.09.002 (Pubitemid 350266454)
18. Malamut G., El Machhour R., Montcuquet N., Martin-Lannerée S., Dusanter-Fourt I., Verkarre V., Mention J. J., Rahmi G., Kiyono H., Butz E. A., Brousse N., Cellier C., Cerf-Bensussan N., Meresse B., IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. The Journal of Clinical Investigation 2010 120 6 2131 2143 2-s2.0-77953192176 10.1172/JCI41344
19. Olaussen R. W., Johansen F. E., Lundin K. E. A., Jahnsen J., Brandtzaeg P., Farstad I. N., Interferon- γ -secreting T cells localize to the epithelium in coeliac disease. Scandinavian Journal of Immunology 2002 56 6 652 664 2-s2.0-0036456903 10.1046/j.1365-3083.2002.01195.x (Pubitemid 35454350)
20. Costantino G., della Torre A., Lo Presti M. A., Caruso R., Mazzon E., Fries W., Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Digestive and Liver Disease 2008 40 1 74 77 2-s2.0-37048999189 10.1016/j.dld.2006.10.017 (Pubitemid 350246383)
21. Gillett H. R., Arnott I. D. R., McIntyre M., Campbell S., Dahele A., Priest M., Jackson R., Ghosh S., Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002 122 3 800 805 2-s2.0-0036183420 (Pubitemid 34173833)
22. Mudler C. J. J., When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. European Journal of Gastroenterology and Hepatology 2001 13 9 1123 1128 2-s2.0-0034813343 10.1097/00042737-200109000-00023 (Pubitemid 32905211)
23. Tack G. J., van Wanrooij R. L., Langerak A. W., Origin and immunophenotype of aberrant IEL in RCDII patients. Molecular Immunology 2012 50 4 262 270
24. Verbeek W. H. M., Goerres M. S., von Blomberg B. M. E., Oudejans J. J., Scholten P. E. T., Hadithi M., Al-Toma A., Schreurs M. W. J., Mulder C. J. J., Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Clinical Immunology 2008 126 1 48 56 2-s2.0-37249046024 10.1016/j.clim.2007.09.002 (Pubitemid 350266454)
25. Bergamaschi C., Bear J., Rosati M., Circulating IL-15 exists as heterodimeric complex with soluble IL-15Ralpha in human and mouse serum. Blood 2012 120 1 e1 e8
26. Forsberg G., Hernell O., Melgar S., Israelsson A., Hammarström S., Hammarström M., Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology 2002 123 3 667 678 2-s2.0-0036728160 10.1053/gast.2002.35355 (Pubitemid 34977072)
27. León F., Sánchez L., Camarero C., Roy G., Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease. Digestive Diseases and Sciences 2005 50 3 593 600 2-s2.0-17444377169 10.1007/s10620-005-2480-5 (Pubitemid 40543754)
28. Kontakou M., Przemioslo R. T., Sturgess R. P., Limb A. G., Ciclitira P. J., Expression of tumour necrosis factor- α interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scandinavian Journal of Gastroenterology 1995 30 5 456 463 2-s2.0-0029010432
29. Przemioslo R. T., Kontakou M., Nobili V., Ciclitira P. J., Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor α in coeliac disease mucosa detected by immunohistochemistry. Gut 1994 35 10 1398 1403 2-s2.0-0027938763 (Pubitemid 24310900)
30. La Scaleia R., Barba M., Di Nardo G., Size and dynamics of mucosal and peripheral IL-17A+ T-cell pools in pediatric age, and their disturbance in celiac disease. Mucosal Immunology 2012 5 5 513 523
31. Hirota K., Ahlfors H., Duarte J. H., Stockinger B., Regulation and function of innate and adaptive interleukin-17-producing cells. EMBO Reports 2012 13 2 113 120
32. Mannon P., Reinisch W., Interleukin 13 and its role in gut defence and inflammation. Gut 2012 61 12 1765 1773
33. Fuss I. J., Heller F., Boirivant M., Leon F., Yoshida M., Fichtner-Feigl S., Yang Z., Exley M., Kitani A., Blumberg R. S., Mannon P., Strober W., Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. The Journal of Clinical Investigation 2004 113 10 1490 1497 2-s2.0-2942536636 10.1172/JCI200419836 (Pubitemid 39071705)
34. Heller F., Fromm A., Gitter A. H., Mankertz J., Schulzke J. D., Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function. Mucosal Immunology 2008 1 supplement 1 S58 S61 2-s2.0-54349114505 10.1038/mi.2008.46
35. Mannon P., Reinisch W., Interleukin 13 and its role in defence and inflammation. Gut 2012 61 12 1765 1773
36. Bernardo D., Garrote J. A., Allegretti Y., Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clinical & Experimental Immunology 2008 154 1 64 73